logo
Health Rounds: Roche/BioNTech experimental vaccine shows early promise in pancreatic cancer

Health Rounds: Roche/BioNTech experimental vaccine shows early promise in pancreatic cancer

Reuters05-03-2025

March 5 (Reuters) - Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche (ROG.S), opens new tab and BioNTech (22UAy.DE), opens new tab following surgery in a small, early trial were still alive, most without disease recurrence, more than three years later, researchers reported.
Typically, the rare long-term survivors of this disease have immune systems that learn to recognize and attack mutant proteins, or neoantigens, in their cancer cells, the study authors noted in a published with their report.
The messenger RNA-based therapeutic cancer vaccine, autogene cevumeran, achieved the same effect in eight of the 16 trial participants, the researchers had earlier reported.
The researchers, whose findings were published in Nature, opens new tab, do not know why only some patients responded to the vaccine.
The vaccine was personalized to deliver instructions that would teach the immune system to recognize each patient's specific tumor cells. Study participants first received surgery, followed by the vaccine and Roche's immunotherapy Tecentriq (atezolizumab), and finally chemotherapy.
At a median follow-up of 3.2 years, six of the eight responders remain cancer-free. The two who relapsed had weaker vaccine-induced immune responses compared with other responders, the researchers reported.
Seven of the eight vaccine non-responders had cancer recurrences at a median of 13.4 months after surgery.
Early-stage trials are designed to test safety, not efficacy, so the researchers cannot say the vaccine caused the delay in cancer recurrence. A larger, mid-stage trial is underway that should be able to shed more insight into the vaccine's efficacy.
'For patients with pancreatic cancer, our latest results continue to support the approach of using personalized mRNA vaccines to target neoantigens in each patient's tumor,' study leader Dr. Vinod Balachandran of Memorial Sloan-Kettering Cancer Center in New York said in a statement.
EPSTEIN-BARR VIRUS BOOSTS CROHN'S DISEASE RISK
Epstein-Barr virus (EBV), which causes mononucleosis, can also increase a person's risk of developing Crohn's disease, a debilitating autoimmune condition of the gastrointestinal tract, researchers have discovered.
EBV is already known to contribute to higher risks for other autoimmune diseases, including multiple sclerosis, lupus and rheumatoid arthritis, but the association with Crohn's had not been recognized.
The researchers analyzed blood samples obtained periodically from a large cohort of young military recruits, looking for antibodies against a wide range of viruses.
Military personnel whose blood contained anti-EBV antibodies, showing they had once been infected, were three times more likely to eventually develop Crohn's disease compared to recruits without these antibodies, the researchers reported in Gastroenterology, opens new tab.
Participants' EBV infections likely preceded their Crohn's diagnosis by five-to-seven years, the researchers said.
Later, in a large group of children whose parents or siblings had Crohn's, the researchers could not find evidence that EBV infections increased the children's risk of developing the disease. They speculated that having first-degree relatives with Crohn's could already have put them at increased risk, muddying the association with EBV.
The researchers want to learn what the Epstein-Barr virus does at a molecular level to make people more susceptible to Crohn's disease.
'Mechanistically, we need to understand exactly how EBV alters the immune system leading to Crohn's disease,' study leader Dr. Scott Snapper of Boston Children's Hospital said in a statement. 'If you could figure out the mechanisms, you could come up with new therapies.'
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
Reporting by Nancy Lapid; editing by Bill Berkrot

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Newly discovered ‘Dragon Prince' dinosaur rewrites family history of T rex
Newly discovered ‘Dragon Prince' dinosaur rewrites family history of T rex

The Independent

time7 hours ago

  • The Independent

Newly discovered ‘Dragon Prince' dinosaur rewrites family history of T rex

A newly discovered dinosaur from Mongolia, named Khankhuuluu mongoliensis, or "Dragon Prince," is believed to be a crucial ancestor of the Tyrannosaurus rex (T rex), shedding light on the T rex's complex evolutionary history. Living approximately 86 million years ago during the Cretaceous Period, Khankhuuluu predates the Tyrannosaurus by around 20 million years. This mid-sized dinosaur, measuring about 13 feet in length and weighing roughly 1,600 pounds, walked on two legs and possessed a long snout filled with sharp teeth. In comparison to the more heavily built T rex, Khankhuuluu's body proportions suggest it was a swift predator, likely hunting smaller prey such as oviraptorosaurs and ornithomimosaurs. The largest known T rex specimen reached a length of 40-1/2 feet. Khankhuuluu means "Dragon Prince" in the Mongolian language. Tyrannosaurus rex means "tyrant king of the lizards." "In the name, we wanted to capture that Khankhuuluu was a small, early form that had not evolved into a king. It was still a prince," said paleontologist Darla Zelenitsky of the University of Calgary in Canada, co-author of the study published on Wednesday in the journal Nature. Tyrannosaurs and all other meat-eating dinosaurs are part of a group called theropods. Tyrannosaurs appeared late in the age of dinosaurs, roaming Asia and North America. Khankhuuluu shared many anatomical traits with tyrannosaurs but lacked certain defining characteristics, showing it was a predecessor and not a true member of the lineage. "Khankhuuluu was almost a tyrannosaur, but not quite. For example, the bone along the top of the snout and the bones around the eye are somewhat different from what we see in tyrannosaurs. The snout bone was hollow and the bones around the eye didn't have all the horns and bumps seen in tyrannosaurs," Zelenitsky said. "Khankhuuluu had teeth like steak knives, with serrations along both the front and back edges. Large tyrannosaurs had conical teeth and massive jaws that allowed them to bite with extreme force then hold in order to subdue very large prey. Khankhuuluu's more slender teeth and jaws show this animal took slashing bites to take down smaller prey," Zelenitsky added. The researchers figured out its anatomy based on fossils of two Khankhuuluu individuals dug up in the 1970s but only now fully studied. These included parts of its skull, arms, legs, tail and back bones. The Khankhuuluu remains, more complete than fossils of other known tyrannosaur forerunners, helped the researchers untangle this lineage's evolutionary history. They concluded that Khankhuuluu was the link between smaller forerunners of tyrannosaurs and later true tyrannosaurs, a transitional animal that reveals how these meat-eaters evolved from speedy and modestly sized species into giant apex predators. "What started as the discovery of a new species ended up with us rewriting the family history of tyrannosaurs," said University of Calgary doctoral student and study lead author Jared Voris. "Before this, there was a lot of confusion about who was related to who when it came to tyrannosaur species." Some scientists had hypothesized that smaller tyrannosaurs like China's Qianzhousaurus - dubbed "Pinnochio-rexes" because of their characteristic long snouts - reflected the lineage's ancestral form. That notion was contradicted by the fact that tyrannosaur forerunner Khankhuuluu differed from them in important ways. "The tyrannosaur family didn't follow a straightforward path where they evolved from small size in early species to larger and larger sizes in later species," Zelenitsky said. Voris noted that Khankhuuluu demonstrates that the ancestors to the tyrannosaurs lived in Asia. "Around 85 million years ago, these tyrannosaur ancestors crossed a land bridge connecting Siberia and Alaska and evolved in North America into the apex predatory tyrannosaurs," Voris said. One line of North American tyrannosaurs later trekked back to Asia and split into two branches - the "Pinnochio-rexes" and massive forms like Tarbosaurus, the researchers said. These apex predators then spread back to North America, they said, paving the way for the appearance of T rex. Tyrannosaurus ruled western North America at the end of the age of dinosaurs when an asteroid struck Earth 66 million years ago. "Khankhuuluu was where it all started but it was still only a distant ancestor of T rex, at nearly 20 million years older," Zelenitsky said. "Over a dozen tyrannosaur species evolved in the time between them. It was a great-great-great uncle, sort of."

Colombian senator Uribe shows signs of neurological improvement after shooting
Colombian senator Uribe shows signs of neurological improvement after shooting

Reuters

time11 hours ago

  • Reuters

Colombian senator Uribe shows signs of neurological improvement after shooting

BOGOTA, June 11 (Reuters) - Colombian Senator Miguel Uribe remains in a critical condition after being shot in Bogota on Saturday, but has shown signs of neurological improvement, the hospital treating him said in a statement on Wednesday. The 39-year-old, a potential presidential contender, is a member of the opposition right-wing Democratic Center party. He was shot in the head as he was addressing a campaign event in a public park in the capital. "Despite the severity of his condition, there are signs of neurological improvement due to a decrease in cerebral edema. There is also evidence of a trend toward hemodynamic stabilization," the Santa Fe Foundation hospital said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store